Clean Science and Technology, via its subsidiary, will exclusively manufacture advanced Hindered Amine Light Stabilizers (HALS) for Switzerland-based Geneus Chem AG. The deal includes warrants for up to a 25% stake in the startup.
Clean Science & Technology Announces Strategic Collaboration
Clean Science and Technology Ltd, through its subsidiary Clean-Fino Chem Limited, has entered a significant long-term strategic collaboration with Switzerland-based Geneus Chem AG (GC).
What just happened
Clean-Fino Chem will exclusively manufacture and supply advanced grades of Hindered Amine Light Stabilizers (HALS) products for Geneus Chem AG. The agreement, dated July 16, 2026, also includes warrants exercisable for up to a 25% stake in GC within four years of issuance.
Why this matters
This collaboration allows Clean Science to expand its specialty chemicals portfolio by securing exclusive global manufacturing rights for advanced HALS. Operations will be based in India, targeting both domestic and international markets, potentially boosting revenue and market share.
The backstory
Geneus Chem AG is an early-stage startup incorporated in 2022 and is not currently operating at a significant scale. This partnership leverages Clean Science's manufacturing capabilities to support the growth of a new entity in the specialty chemicals sector.
What changes now
Clean Science will establish domestic manufacturing for advanced HALS products, benefiting from exclusive global rights. The company also gains a future opportunity to increase its investment in Geneus Chem AG through warrants.
Risks to watch
Investors should be aware that Geneus Chem AG is an early-stage startup with limited current operational scale. The success of the venture hinges on the effective execution of the partnership and the scaling of Geneus Chem AG's business.
Peer comparison
While specific peer manufacturing agreements for HALS are not detailed in the filing, Clean Science's focus on specialty chemicals and expanding its product offerings is a common strategy within the chemical industry to enhance value addition and market reach.
Context metrics
- Agreement Date: July 16, 2026
- Equity Incentive: Warrants for up to 25% stake in GC (fully diluted)
- Exercise Period for Warrants: Within 4 years from issuance
What to track next
Monitor the progress of manufacturing operations, the scaling of Geneus Chem AG, and the potential exercise of warrants by Clean Science for its stake in the Swiss partner.